| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Total Assets  | 6,479 | 7,360 | 8,119 | 8,613 | 9,183 | 11,338 | 11,417 | 13,269 | 14,428 | 16,753 | 20,657 |
| Fixed Assets | 3,244 | 3,997 | 4,591 | 4,773 | 4,982 | 7,432 | 6,778 | 8,296 | 8,520 | 9,664 | 10,879 |
| Current Assets | 1,939 | 1,975 | 2,129 | 2,220 | 2,282 | 2,647 | 3,641 | 4,061 | 4,337 | 5,280 | 7,029 |
| Capital Work in Progress | 533 | 562 | 347 | 712 | 822 | 236 | 234 | 46 | 610 | 873 | 771 |
| Investments | 146 | 352 | 406 | 352 | 462 | 434 | 1,343 | 816 | 574 | 986 | 481 |
| Other Assets | 2,557 | 2,448 | 2,775 | 2,776 | 2,918 | 3,237 | 3,062 | 4,112 | 4,725 | 5,230 | 0 |
| Total Liabilities | 6,479 | 7,360 | 8,119 | 8,613 | 9,183 | 11,338 | 11,417 | 13,269 | 14,428 | 16,753 | 20,657 |
| Current Liabilities | 1,076 | 1,250 | 963 | 1,567 | 1,956 | 2,337 | 2,038 | 2,434 | 3,325 | 4,665 | 4,579 |
| Non Current Liabilities | 2,159 | 2,701 | 3,718 | 3,662 | 3,759 | 5,531 | 4,577 | 4,932 | 4,572 | 4,768 | 7,426 |
| Total Equity | 3,244 | 3,409 | 3,438 | 3,384 | 3,469 | 3,470 | 4,802 | 5,903 | 6,531 | 7,321 | 8,212 |
| Reserve & Surplus | 3,101 | 3,262 | 3,240 | 3,182 | 3,264 | 3,270 | 4,531 | 5,551 | 6,126 | 6,864 | 8,140 |
| Share Capital | 70 | 70 | 70 | 70 | 70 | 70 | 72 | 72 | 72 | 72 | 72 |
Apollo Hospitals
7,553.50
-11.50
(-0.15%)
Market Cap
1,08,607.70 Cr
EPS
100.56
PE Ratio
75.12
Dividend Yield
0.37 %
Industry
Healthcare Services52 Week High
7,600.50
52 Week Low
6,001.00
PB Ratio
13.24
Debt to Equity
0.74
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from25 analysts
Company News
View All News
A block trade of approximately 72,508 shares of Apollo Hospitals Enterprise Ltd. occurred on the National Stock Exchange (NSE). The shares were traded at a price of Rs. 7500.50 per share, resulting in a total transaction value of Rs. 54.38 crores.
Apollo Hospitals Enterprise Ltd. announces a strategic demerger to separate its core healthcare services from its digital health and pharmacy distribution business. The move aims to provide sharper focus and dedicated leadership for each entity.
Apollo Hospitals is creating a new listed entity by consolidating its pharmacy, digital health, and pharma distribution businesses. Shareholders will receive 195.2 shares of the new company for every 100 shares held. The new entity aims for ₹25,000 crore revenue by FY25 with a 7% EBITDA margin. Listing expected within 18-21 months.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,298.20 | #1 1,26,204.10 | 111.47 | 7,028.46 | 18.77 | 1,070 | 26.84 | 66.67 | |
7,553.50 | #2 1,08,607.70 | #7 75.12 | #1 21,794.00 | #6 14.74 | #2 1,513 | #2 60.41 | 70.65 | |
807.05 | 60,928.90 | 71.95 | 7,782.75 | 8.99 | 809 | -7.43 | 67.42 | |
2,011.40 | 41,105.10 | #1 51.59 | 5,482.98 | 10.96 | 807 | 3.41 | 55.67 | |
633.15 | 32,804.80 | 88.45 | 4,138.46 | 22.85 | #1 5,417 | #1 3,986.36 | 66.33 | |
1,183.80 | 31,795.40 | 61.28 | 3,692.32 | #1 25.09 | 486 | -20.35 | 52.92 | |
686.05 | 27,451.50 | 72.89 | 3,035.10 | 12.94 | 409 | 48.39 | 57.58 | |
1,599.40 | 16,242.20 | 68.30 | 1,566.90 | 17.46 | 244 | 10.57 | 66.99 | |
1,506.50 | 9,877.50 | 52.43 | 1,290.20 | 17.77 | 194 | -0.88 | 55.50 | |
566.30 | 7,895.10 | 177.55 | 2,218.14 | 12.97 | 28 | -71.06 | 58.80 |
Forecast
Actual
Growth Rate
Revenue Growth
14.74 %
Net Income Growth
3.32 %
Cash Flow Change
39.46 %
ROE
-7.80 %
ROCE
9.18 %
EBITDA Margin (Avg.)
1.72 %
Balance Sheet
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 103 | 39 | -52 | 24 | -20 | 95 | 45 | 158 | -113 | 72 |
| Investing Activities | -759 | -888 | -1,152 | -405 | -711 | -289 | -880 | -747 | -857 | -1,537 |
| Operating Activities | 470 | 597 | 623 | 537 | 905 | 1,293 | 1,265 | 1,696 | 1,377 | 1,920 |
| Financing Activities | 392 | 330 | 477 | -109 | -215 | -910 | -340 | -792 | -633 | -311 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 29.82 % | 29.82 % | 29.82 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.34 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 45.63 % | 43.92 % | 45.37 % | 45.27 % | 42.74 % |
| DIIs | 9.16 % | 10.84 % | 12.24 % | 12.13 % | 12.45 % | 14.89 % | 14.59 % | 16.56 % | 17.76 % | 16.31 % | 18.60 % | 17.97 % | 19.55 % | 21.14 % | 19.95 % | 19.98 % | 22.29 % |
| Government | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % |
| Public / Retail | 4.07 % | 3.99 % | 4.24 % | 4.03 % | 4.27 % | 4.48 % | 4.23 % | 4.13 % | 4.04 % | 3.90 % | 4.04 % | 3.70 % | 3.74 % | 3.81 % | 3.62 % | 3.65 % | 3.81 % |
| Others | 56.73 % | 55.13 % | 53.47 % | 54.29 % | 53.73 % | 51.07 % | 51.63 % | 49.75 % | 48.64 % | 50.23 % | 47.80 % | 48.76 % | 1.52 % | 1.57 % | 1.50 % | 1.54 % | 1.60 % |
| No of Share Holders | 67,091 | 75,153 | 98,452 | 99,135 | 1,26,226 | 1,46,320 | 1,35,923 | 1,31,636 | 1,31,937 | 1,20,030 | 1,31,565 | 1,19,578 | 1,30,664 | 1,27,754 | 1,19,245 | 1,27,802 | 1,34,058 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 6 | 5 | 6 | 6 | 3 | 11.75 | 15 | 16 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.56 | 0.41 | 0.53 | 0.21 | 0.07 | 0.27 | 0.24 | 0.24 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 29 Aug 2025 |  Annual General Meeting | NA | 29 Aug 2025 | 6,878.20 | 7,553.50 |
| 30 May 2025 |  Quarterly Result Announcement | NA | 30 May 2025 | 7,004.30 | 6,878.20 |
| 15 Feb 2025 |  Dividend | ₹ 9.00 /share | 14 Feb 2025 | 6,766.00 | 6,266.65 |
| 10 Feb 2025 | Quarterly Result Announcement | NA | 10 Feb 2025 | 6,828.10 | 6,766.00 |
| 06 Nov 2024 | Quarterly Result Announcement | NA | 06 Nov 2024 | 7,139.90 | 6,969.85 |
| 30 Aug 2024 | Annual General Meeting | NA | 30 Aug 2024 | 6,687.60 | 6,927.50 |
| 17 Aug 2024 | Dividend | ₹ 10.00 /share | 16 Aug 2024 | 5,761.00 | 6,686.90 |
| 20 Feb 2024 | Dividend | ₹ 6.00 /share | 20 Feb 2024 | 6,231.00 | 6,759.45 |
| 19 Aug 2023 | Dividend | ₹ 9.00 /share | 18 Aug 2023 | 4,599.15 | 4,848.35 |
| 24 Feb 2023 | Dividend | ₹ 6.00 /share | 24 Feb 2023 | 4,268.85 | 4,470.65 |
| 20 Aug 2022 | Dividend | ₹ 11.75 /share | 18 Aug 2022 | 3,668.00 | 4,135.35 |
| 21 Aug 2021 | Dividend | ₹ 3.00 /share | 18 Aug 2021 | 3,203.70 | 4,746.50 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Scheme of Arrangement5 days ago
5 days agoClosure of Trading WindowJun 23, 2025
Jun 23, 2025Announcement under Regulation 30 (LODR)-AcquisitionJun 10, 2025
Jun 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 06, 2025
Jun 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 31, 2025
May 31, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 31, 2025
May 31, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionMay 31, 2025
May 31, 2025Outcome Of Board Meeting - Appointment Of Secretarial AuditorsMay 30, 2025
May 30, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 30, 2025
May 30, 2025Announcement under Regulation 30 (LODR)-Date of payment of DividendMay 30, 2025
May 30, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 30, 2025
May 30, 2025Announcement under Regulation 30 (LODR)-AcquisitionMay 30, 2025
May 30, 2025AGM On 29Th August 2025May 30, 2025
May 30, 2025Outcome Of Board Meeting - Reappointment Of Executive Directors And Independent DirectorMay 30, 2025
May 30, 2025Fixation Of Record DateMay 30, 2025
May 30, 2025Board Meeting Outcome for Outcome Of The Board MeetingMay 30, 2025
May 30, 2025Audited Financial Results For The Quarter And Year Ended 31St March 2025May 30, 2025
May 30, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 20, 2025
May 20, 2025Merger Of Wholly Owned Subsidiary Of Apollo Hospitals International Limited (AHIL) A Subsidiary Of The Company Into AHIL.May 16, 2025
May 16, 2025Board Meeting Intimation for Notice Of Board MeetingMay 06, 2025
May 06, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Apr 10, 2025Closure of Trading WindowMar 24, 2025
Mar 24, 2025Disclosure Pursuant To Regulation 30 Of SEBI LODRMar 21, 2025
Mar 21, 2025Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (Listing Regulations)Mar 14, 2025
Mar 14, 2025Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)Mar 04, 2025
Mar 04, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - RevisedMar 04, 2025
Mar 04, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 04, 2025
Mar 04, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 04, 2025
Mar 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 12, 2025
Feb 12, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 10, 2025
Feb 10, 2025Integrated Filing (Financial)Feb 10, 2025
Feb 10, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 10, 2025
Feb 10, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesFeb 10, 2025
Feb 10, 2025Board Meeting Outcome for Outcome Of The Board MeetingFeb 10, 2025
Feb 10, 2025Unaudited Financial Results For Three And Nine Months Ended 31St December 2024Feb 10, 2025
Feb 10, 2025Update on board meetingFeb 05, 2025
Feb 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2025
Jan 30, 2025Board Meeting Intimation for Notice Of The Board MeetingJan 18, 2025
Jan 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 11, 2025
Jan 11, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011Nov 28, 2024
Nov 28, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 15, 2024
Nov 15, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 12, 2024
Nov 12, 2024Technical Indicators
RSI(14)
Neutral 70.65
ATR(14)
Less Volatile 131.91
STOCH(9,6)
Overbought 87.28
STOCH RSI(14)
Overbought 93.11
MACD(12,26)
Bullish 56.02
ADX(14)
Strong Trend 29.15
UO(9)
Bearish 61.36
ROC(12)
Uptrend And Accelerating 8.94
WillR(14)
Overbought -6.83
Mutual Fund Holdings
Kotak Arbitrage Fund Direct-Growth 
Aditya Birla Sun Life Large Cap Direct Fund-Growth 
Bandhan Large & Mid Cap Fund Direct-Growth 
Tata Arbitrage Fund Direct - Growth 
HDFC Arbitrage Fund Wholesale Direct-Growth 
Mirae Asset Midcap Fund Direct - Growth 
JM Flexicap Fund Direct Plan-Growth 
UTI Mid Cap Fund Direct-Growth 
Invesco India Arbitrage Fund Direct-Growth 
ICICI Prudential Equity Arbitrage Direct-Growth 
SBI Arbitrage Opportunities Fund Direct-Growth 
Edelweiss Arbitrage Fund Direct-Growth 
Shriram Multi Sector Rotation Fund Direct-Growth 
Nippon India Arbitrage Fund Direct-Growth 
Axis ELSS Tax Saver Direct Plan-Growth About Apollo Hospitals
Apollo Hospitals Enterprise Limited (AHEL) is a leading private healthcare provider in Asia. It operates a network of hospitals, pharmacies, primary care clinics, and diagnostic centers. As of March 31, 2023, AHEL had a capacity of 9,957 beds across 70 hospitals in India and overseas. This includes 8,544 beds in 43 owned hospitals, 305 beds in 11 cradles, 257 beds in 11 day care/short surgical stay centers, and 851 beds in 5 hospitals operated through management contracts. The company has expanded through acquisitions, joint ventures, and new facility launches. AHEL has also diversified into health insurance, retail pharmacy, and digital healthcare platforms. The company has undergone various corporate restructurings to optimize its business operations across different healthcare segments.
Chairperson NameShobana Kamineni
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
